Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A single-center, retrospective cohort study assessing the clinical experience and adherence to the treatment protocol in the management of for COVID-19 pneumonia along with assessment of IVIg treatment benefit and survival parameters improvement in Kidney transplant recipients in Kidney transplant recipients

Next Previous
X
Search
Trial Profile

A single-center, retrospective cohort study assessing the clinical experience and adherence to the treatment protocol in the management of for COVID-19 pneumonia along with assessment of IVIg treatment benefit and survival parameters improvement in Kidney transplant recipients in Kidney transplant recipients

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Sep 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Enoxaparin sodium (Primary) ; Favipiravir (Primary) ; Immunoglobulins (Primary) ; Linezolid (Primary) ; Meropenem (Primary) ; Methylprednisolone (Primary) ; Moxifloxacin (Primary) ; Piperacillin/tazobactam (Primary) ; Tocilizumab (Primary)
  • Indications COVID 2019 infections; COVID-19 pneumonia
  • Focus Therapeutic Use

    • Most Recent Events

    • 01 Oct 2021 Results published in the Journal of Medical Virology
    • 01 Sep 2021 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top